Cite
HARVARD Citation
Bossa, F. et al. (2021). Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs. Digestive and liver disease. 53 (3), pp. 277-282. [Online].